Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Advances in understanding prognosis in myeloma.

British journal of haematology - 1 Nov 2016

Smith Dean, Yong Kwee

Abstract excerpt

In the last two decades outcomes in multiple myeloma (myeloma) have greatly improved, due to the introduction of newer, more effective therapies. This improvement is not uniform. Response to treatment and survival remains heterogeneous, with some patients living for 1-2 years whilst others are alive and progression-free at 10 years. This variation in outcome is due to patient characteristics plus features...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Combined Modality Therapy
Share to Comorbidity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Multimodal Imaging

Share to Multiple Myeloma

Share to Neoplasm Staging

Share to Transcriptome

Source

Identifiers

PMID: 27604166
DOI: 10.1111/bjh.14304

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Advances in understanding prognosis in myeloma.PMID 27604166Read ↗

Towards Stratified Medicine in Plasma Cell Myeloma.Semantic proximity Read ↗

Current Review on High-Risk Multiple Myeloma.Semantic proximity Read ↗

Management of high-risk Myeloma: an evidence-based review of treatment strategies.Semantic proximity Read ↗

Biologic frontiers in multiple myeloma: from biomarker identification to clinical practice.Semantic proximity Read ↗

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity Read ↗

Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideSemantic proximity Read ↗

Prognostic factors and staging in multiple myeloma.Semantic proximity Read ↗

Multiple myeloma.Semantic proximity Read ↗

New Targets and New Agents in High-Risk Multiple Myeloma.Semantic proximity Read ↗

New insights in the clinical biology of multiple myeloma.Semantic proximity Read ↗

Implications of heterogeneity in multiple myeloma.Semantic proximity Read ↗

Myeloma Is Not a Single Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.